A New Mutation Found in Newborn Screening for Fabry Disease Evaluated by Plasma Globotriaosylsphingosine Levels

Human Genome Variation - United Kingdom
doi 10.1038/hgv.2017.2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Newborn Screening for Fabry Disease in Japan: Prevalence and Genotypes of Fabry Disease in a Pilot Study

Journal of Human Genetics
Genetics
2013English

High Incidence of Later-Onset Fabry Disease Revealed by Newborn Screening*

American Journal of Human Genetics
Genetics
2006English

Vascular Aspects of Fabry Disease in Relation to Clinical Manifestations and Elevations in Plasma Globotriaosylsphingosine * Novelty and Significance

Hypertension
Internal Medicine
2012English

Screening for Fabry Disease in Patients With Chronic Kidney Disease: Limitations of Plasma -Galactosidase Assay as a Screening Test

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2007English

Screening, Diagnosis and Treatment of Fabry Disease

Clinical pharmacology and therapy
2019English

Newborn Screening for Sickle Cell Disease in St. Vincent and the Grenadines: Results of a Pilot Newborn Screening Program

Global Pediatric Health
Child HealthPediatricsPerinatology
2017English

Update: Newborn Screening for Sickle Cell Disease—California, Illinois, and New York, 1998

JAMA - Journal of the American Medical Association
Medicine
2000English

Mass Screening of the Newborn for Metabolic Disease.

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1968English

Cognitive Impairment and Fabry Disease: A Case Report With Mutation S126G

Neuropsychological Trends
Molecular NeurosciencePhysiological PsychologyNeuropsychologyCellular
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy